Pseudoxanthoma Elasticum: Clinical Trials

1 trial for Pseudoxanthoma Elasticum, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Pseudoxanthoma Elasticum: new trials by email Literature Review of Pseudoxanthoma Elasticum trials Research Report on Pseudoxanthoma Elasticum

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum
Etidronate, Placebo - Pseudoxanthoma Elasticum
Phase 3RecruitingUMC Utrecht762023-04-262023-04-27

Broader conditions

Cardiovascular Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Skin Abnormalities (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Vascular Diseases (1)

Interventions

Etidronic Acid (1)

Sponsors

UMC Utrecht (1)

Countries

Netherlands (1)

Results publications

PMID 41131563